Chen Jun-xi, Sun Jian, Liu Yan-yang, Jia Bao-hui
Intensive Care Unit, Fourth Affiliated Hospital, Nanchang University, Nanchang 330003, China.
Zhonghua Yi Xue Za Zhi. 2013 Apr 23;93(16):1243-6.
To explore the effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients.
A total of 16 severe septic patients underwent mechanical ventilation from June 2012 to December 2012 at Fourth Affiliated Hospital of Nanchang University. There were 14 males and 2 females with a mean age of (58 ± 6) years (range: 48 - 67 years). Among them, there were multiple trauma (n = 4), acute severe pancreatitis (n = 6) and recent tumorectomy for gastrointestinal cancer (n = 6). The adrenergic beta-1 antagonist esmolol was injected through central venous catheter to reduce heart rate by 20% from baseline. Various indices (heart rate, systolic blood pressure, diastolic blood pressure, cardiac output, cardiac index, central venous pressure, pulmonary artery wedge pressure, pulmonary vascular resistance index, systemic vascular resistance index and stroke volume index) were monitored by a multifunctional and hemodynamic monitor connected to pulmonary artery catheter. And other indices of arterial pressure of carbon dioxide (PaCO2), lactate (Lac) concentration, superior vena cava oxygen saturation (ScvO2), superior vena cava carbon dioxide pressure (PcvO2) and central venous-to-arterial carbon dioxide tension difference (Pcv-aCO2) were measured by a blood-gas-analyzer before 10 minutes and after 3 hours of dosing.
Heart rate and cardiac index decreased significantly at 3 hours post-dosing compared with that at pre-dosing ((91 ± 13) vs (114 ± 15) beats per minute, (3.4 ± 0.7) vs (4.2 ± 0.8) L×min(-1)×m(-2), P < 0.05), but systolic blood pressure, diastolic blood pressure, central venous pressure, pulmonary wedge pressure, pulmonary vascular resistance index, systemic vascular resistance index and stroke index showed no significant changes ((100 ± 13) vs (108 ± 14) mm Hg (1 mm Hg = 0.133 kPa), (62 ± 7) vs (64 ± 6) mm Hg, (11.8 ± 2.5) vs (12.1 ± 2.4) mm Hg, (13 ± 5) vs (14 ± 4) mm Hg, (201 ± 72) vs (179 ± 95) dyn×s/(cm(5)×m(2)), (1360 ± 520) vs (1366 ± 538) dyn×s/(cm(5)×m(2)), (40 ± 9) vs (38 ± 6) ml/(beat×m(2)), all P > 0.05). ScvO2, Lac and Pcv-aCO2 also showed no significant change ((72.8 ± 5.3)% vs (70.1 ± 4.0)%, (2.11 ± 0.13) vs (2.31 ± 0.23) mmol/L, (3.9 ± 1.0) vs (4.5 ± 0.8) mm Hg, all P > 0.05).
Adrenergic beta-1 antagonist may reduce cardiac output in proportion to the percentage decreases in heart rate in severe septic patients without adverse effects upon cardiac function and systemic perfusion.
探讨肾上腺素能β-1受体拮抗剂对重症脓毒症患者血流动力学的影响。
选取2012年6月至2012年12月在南昌大学第四附属医院接受机械通气的16例重症脓毒症患者。其中男性14例,女性2例,平均年龄(58±6)岁(范围:48 - 67岁)。其中,多发伤4例,急性重症胰腺炎6例,近期胃肠道癌肿瘤切除术6例。通过中心静脉导管注射肾上腺素能β-1受体拮抗剂艾司洛尔,使心率从基线降低20%。通过连接肺动脉导管的多功能血流动力学监测仪监测各项指标(心率、收缩压、舒张压、心输出量、心脏指数、中心静脉压、肺动脉楔压、肺血管阻力指数、全身血管阻力指数和每搏量指数)。并在给药前10分钟和给药后3小时用血气分析仪测量动脉二氧化碳分压(PaCO2)、乳酸(Lac)浓度、上腔静脉血氧饱和度(ScvO2)、上腔静脉二氧化碳分压(PcvO2)和中心静脉 - 动脉二氧化碳分压差(Pcv - aCO2)等其他指标。
给药后3小时与给药前相比,心率和心脏指数显著下降((91±13)次/分钟 vs (114±15)次/分钟,(3.4±0.7)L×min(-1)×m(-2) vs (4.2±0.8)L×min(-1)×m(-2),P < 0.05),但收缩压、舒张压、中心静脉压、肺楔压、肺血管阻力指数、全身血管阻力指数和每搏指数无显著变化((100±13)mmHg(1 mmHg = 0.133 kPa)vs (108±14)mmHg,(62±7)mmHg vs (64±6)mmHg,(11.8±2.5)mmHg vs (12.1±2.4)mmHg,(13±5)mmHg vs (14±4)mmHg,(201±72)dyn×s/(cm(5)×m(2)) vs (179±95)dyn×s/(cm(5)×m(2)),(1360±520)dyn×s/(cm(5)×m(2)) vs (1366±538)dyn×s/(cm(5)×m(2)),(40±9)ml/(beat×m(2)) vs (38±6)ml/(beat×m(2)),所有P > 0.05)。ScvO2、Lac和Pcv - aCO2也无显著变化((72.8±5.3)% vs (70.1±4.0)%,(2. / 11±0.13)mmol/L vs (2.31±0.23)mmol/L,(3.9±1.0)mmHg vs (4.5±0.8)mmHg,所有P > 0.05)。
肾上腺素能β-1受体拮抗剂可能按心率降低的百分比成比例地降低重症脓毒症患者的心输出量,且对心功能和全身灌注无不良影响。